FindTrial
Sign In

A study to compare the efficacy of Injection Carbetocin with Injection Oxytocin to prevent postpartum haemorrhage

A comparative study of Injection Carbetocin with Injection Oxytocin for the prevention of postpartum haemorrhage.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052339
Enrollment
80
Registered
2023-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Injection Carbetocin: Efficacy in the prevention of post partum hemorrhage Dose: 100 mcg IV single dose after delivery of placenta Control Intervention1: Injection Oxytocin: Efficacy in

Sponsors

GMERS MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Primigravida 2) Multigravida 3) Singleton pregnancy 4) Multiple pregnancy 5) Previous cesarean section 6) Currently undergoing normal, instrumental delivery or C-section.

Exclusion criteria

Exclusion criteria: 1) High blood pressure (eclampsia, pre eclampsia, gestational hypertension, chronic hypertension) 2) Cardiovascular problems 3) Known contraindication to Inj Carbetocin or Inj Oxytocin

Design outcomes

Primary

MeasureTime frame
Number of patients developing PPH after Inj Carbetocin and number of patients developing PPH after Inj OxyotcinTimepoint: First 24 hours after delivery—

Secondary

MeasureTime frame
Number of patients developing side effects of Injection Carbetocin and Injection OxytocinTimepoint: First 24 hours after delivery—

Countries

India

Contacts

Public ContactDr Shreya Dipak Mehta

GMERS MEDICAL COLLEGE AND HOSPITAL, GOTRI VADODARA

Drashishshah2001@yahoo.com8849450012

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026